Abstract: A method of compounding a topical cream includes combining ingredients including lidocaine hydrochloride, 4%, topical solution, diclofenac sodium, 1.5%, topical solution, lidocaine hydrochloride USP powder, and diclofenac sodium powder.

Abstract: A method of making a pharmaceutical composition for delivery to the lower respiratory tract via nebulization within a sterile diluent includes mixing dry powder ingredients including a beta agonist or anticholinergic and one or more additional ingredients to formulate a dry powder mixture for mixing with the sterile diluent.

Abstract: A method of treating migraines includes administering a pharmaceutically effective amount of a topical composition comprising an anhydrous suspension including a triptan to an oral cavity of a subject for oral absorption therein. The topical composition is formulated to self-emulsify in an aqueous environment of the oral cavity.

Abstract: A method of powderizing a dry cake pharmaceutical drug product for injection within a vial may include securing a vial containing a dry cake pharmaceutical drug product for injection to a shaker device and powderizing the dry cake pharmaceutical drug product within the vial by shaking the vial with the shaker device operated at between about 100 to about 5000 cycles per minute for between about 10 minutes and about 1 hour.

Abstract: A topical composition for treating fungal skin infections with associated inflammation may include making or administering to the affected skin area an antifungal and steroid, such as a corticosteroid. Certain compositions may include antifungals such as itraconazole or econazole and corticosteroids such as fluticasone, fluocinonide, or clobetasol. The antifungal and steroid may be within a cream. In one example, a commercially available econazole nitrate cream may be used in conjunction with a commercially available fluocinonide cream or commercially available clobetasol cream to treat the affected skin area.

Abstract: A method of treating or preventing one or both of a bacterial infection or fungal infection of a foot of a subject includes combining a diluent and at least one of a clindamycin solution or an erythromycin solution to form a footbath solution. The method may further include topically administering the footbath solution to the subject. Administering may include contacting with the footbath solution a skin area of the foot of the subject that is infected or suspected to be infected.

Abstract: A method of treating a wound may include topically administering a statin composition including a statin selected from atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, simvastatin, or combination thereof. The statin composition may be administered in an ointment, powder, or liquid format. The method may also include topically administering one or more antimicrobial drugs and/or naltrexone.

Abstract: A method of treating type-2 diabetes, chronic weight maintenance, or overindulgence conditions includes administering a pharmaceutically effective amount of a topical composition comprising a GLP-1 receptor agonist suspended in an anhydrous suspension base vehicle to an oral cavity of a subject for oral absorption therein. The topical composition is formulated to form a self-emulsifying liposome in an aqueous environment of the oral cavity.

Abstract: A process for the separation of 99mTc from molybdenum targets is described. The method for separation of 99mTc isotope from molybdenum targets includes: i) providing an initial multicomponent mixture of elements, the mixture containing 99mTc; ii) dissolving the multicomponent mixture of elements with an oxidizing agent to oxidize the mixture of elements; iii) heating the mixture of elements at a temperature sufficiently high enough to sublimate a vaporized compound containing 99mTc; iv) condensing the vaporized compound containing 99mTc to form a reaction product; v) adding a base to the condensed reaction product to dissolve the 99mTc containing reaction product to form sodium pertechnetate (Na99mTcO4); and vii) purifying the crude solution of sodium pertechnetate Na99mTcO4 using column chromatography to provide the 99mTc isotope as a radiochemical compound.

Abstract: A method of powderizing a dry cake pharmaceutical drug product for injection within a vial may include securing a vial containing a dry cake pharmaceutical drug product for injection to a shaker device and powderizing the dry cake pharmaceutical drug product within the vial by shaking the vial with the shaker device operated at between about 100 to about 5000 cycles per minute for between about 10 minutes and about 1 hour.

Abstract: A method of treating a wound may include topically administering a statin composition including a statin selected from atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, simvastatin, or combination thereof. The statin composition may be administered in an ointment, powder, or liquid format. The method may also include topically administering one or more antimicrobial drugs and/or naltrexone.

Abstract: This invention classifies an action that appears in a video clip by receiving a video clip for analysis, applying a convolutional neural network mechanism (CNN) to the frames in the clip to generate a 4D embedding tensor for each frame in the clip, applying a multi-resolution convolutional neural network mechanism (CNN) to each of the frames in the clip to generate a sequence of reduced resolution blocks, computing a kinematic attention weight that estimates the amount of motion in the block, applying the attention weights to the embedding tensors for each frame in a clip, to generate a weighted embedding tensor, or context, that represents all the frames in the clip, at the resolution, combining the contexts across all resolutions to generate a multi-resolution context, performing a 3D pooling to obtain a 1D feature vector and classifying a primary action of the video clip based on the feature vector.

Abstract: A method of compounding a topical cream includes combining ingredients including lidocaine hydrochloride, 4%, topical solution, diclofenac sodium, 1.5%, topical solution, lidocaine hydrochloride USP powder, and diclofenac sodium powder.

Abstract: A topical composition for treating fungal skin infections with associated inflammation may include making or administering to the affected skin area an antifungal and steroid, such as a corticosteroid. Certain compositions may include antifungals such as itraconazole or econazole and corticosteroids such as fluticasone, fluocinonide, or clobetasol. The antifungal and steroid may be within a cream. In one example, a commercially available econazole nitrate cream may be used in conjunction with a commercially available fluocinonide cream or commercially available clobetasol cream to treat the affected skin area.

Abstract: This invention predicts results for a media clip posted to a social media influencer channel by maintaining a database of results data for media clips where an influencer channel includes media clips that include unstructured data, and structured data, and then provide to a first machine learning model a first set of channel data, extracting a first set of features, predicting a value for the first target variable, providing to a second machine learning model a second set of channel data including a second selection of structured data, and the predicted value of the first target variable, extracting a second set of features, and predicting a value for the second target variable.

Abstract: A method of treating a bacterial infection of a subject includes topically administering a topical composition that includes nitrofurantoin combined with a carrier. The topical composition may be administered by contacting a tissue surface of the subject to be treated with the topical composition such as skin or mucosal tissue.

Abstract: A method of managing non-infective nasal symptoms may include formulating a topical composition for nasal administration. The formulation may include zinc, acetylcysteine, azelastine, one or more probiotics, or a combination thereof. The formulation may also include additional ingredients such as a steroid, poloxamers, or xylitol. Ingredients of the topical composition may be provided in a dry powder format within a capsule for combining with an aqueous diluent at the time of administration. The topical composition may be administered nasally.

Abstract: A method of compounding a topical cream includes combining ingredients including lidocaine hydrochloride, 4%, topical solution, diclofenac sodium, 1.5%, topical solution, lidocaine hydrochloride USP powder, and diclofenac sodium powder.

Abstract: A topical nail treat may include a topical nail solution including flucytosine, clotrimazole, diclofenac and DMSO. The topical nails solution may be applied to nail surfaces to treat or prevent a nail infection. A gel or ointment may be applied to nails over the topical nail solution.

Abstract: A method of making a pharmaceutical composition for delivery to the lower respiratory tract via nebulization within a sterile diluent includes mixing dry powder ingredients including a beta agonist or anticholinergic and one or more additional ingredients to formulate a dry powder mixture for mixing with the sterile diluent.